Sverige - svenska - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - atazanavirsulfat - kapsel, hård - 300 mg - laktosmonohydrat hjälpämne; atazanavirsulfat 342 mg aktiv substans; propylenglykol hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - atazanavirsulfat - kapsel, hård - 200 mg - laktosmonohydrat hjälpämne; atazanavirsulfat 228 mg aktiv substans; propylenglykol hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - atazanavirsulfat - kapsel, hård - 150 mg - propylenglykol hjälpämne; atazanavirsulfat 171 mg aktiv substans; laktosmonohydrat hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bracco international bv - gadoteridol - injektionsvätska, lösning i förfylld spruta - 279,3 mg/ml - gadoteridol 279,3 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bionorica se - gentiana lutea(gullgentiana) torkad rot/primula veris(gullviva) torkad blomma/rumex crispus(krusskräppa) torkad ört/sambucus nigra(fläder) torkad blomma/verbena officinalis(järnört) torkad ört; torrt extrakt (3-6:1); 1. etanol 59% 2. vatten - dragerad tablett - sackaros hjälpämne; gentiana lutea(gullgentiana) torkad rot/primula veris(gullviva) torkad blomma/rumex crispus(krusskräppa) torkad ört/sambucus nigra(fläder) torkad blomma/verbena officinalis(järnört) torkad ört; torrt extrakt (3-6:1); 1. etanol 59% 2. vatten 160 mg aktiv substans; glukos, flytande hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

albireo - odevixibat - cholestasis, intrahepatic - gall- och leverterapi - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 och 5.

Europeiska unionen - svenska - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastiska medel - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

adamed pharma s.a. - cytisiniklin - filmdragerad tablett - 1,5 mg - cytisiniklin 1,5 mg aktiv substans; aspartam hjälpämne; mannitol hjälpämne; glycerol hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.